Wolff Wiese Magana’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-450
Closed -$554 997
2024
Q2
$554 Hold
450
﹤0.01% 697
2024
Q1
$358 Hold
450
﹤0.01% 657
2023
Q4
$429 Hold
450
﹤0.01% 635
2023
Q3
$486 Hold
450
﹤0.01% 696
2023
Q2
$404 Hold
450
﹤0.01% 715
2023
Q1
$381 Hold
450
﹤0.01% 676
2022
Q4
$418 Hold
450
﹤0.01% 662
2022
Q3
$1K Hold
450
﹤0.01% 740
2022
Q2
$1K Hold
450
﹤0.01% 763
2022
Q1
$2K Hold
450
﹤0.01% 715
2021
Q4
$2K Buy
450
+150
+50% +$920 ﹤0.01% 717
2021
Q3
$2K Hold
300
﹤0.01% 702
2021
Q2
$4K Hold
300
﹤0.01% 647
2021
Q1
$2K Buy
+300
New +$3.38K ﹤0.01% 663

Other funds holding CLOV

Wolff Wiese Magana's CLOV Position: Q3 2024 in Review

Wolff Wiese Magana sold out of Clover Health Investments (CLOV) in Q3 2024, closing a stake of 450 shares — an estimated $554 sold.

Wolff Wiese Magana first reported a position in CLOV in Q1 2021 and held it in 14 quarters. The position peaked at $4K in Q2 2021. 159 funds tracked by Wall St. Rank hold CLOV as of Q3 2024.

  • Wolff Wiese Magana reported no remaining Clover Health Investments position as of Q3 2024 after selling out during the quarter.
  • Wolff Wiese Magana sold 450 Clover Health Investments shares in Q3 2024, an estimated $554.
  • Wolff Wiese Magana first reported a position in Clover Health Investments in Q1 2021 and held it in 14 quarters.
  • Wolff Wiese Magana's Clover Health Investments position peaked at $4K in Q2 2021.
  • 159 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2024.

Based on Wolff Wiese Magana's 13F filing for Q3 2024, filed 16 Oct 2024.